My motion is based on the discussion at our last committee meeting, where we heard from some of the pharmaceutical industry and the generic industry. There were many unanswered questions about the change that has been proposed by the federal government to the regulations under the Patent Act. One of the problems seemed to be lack of notification and the very short consultation period. So my motion basically is calling for a halt on making a change until there has been more public consultation. That's the nub of my motion.
